![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie](https://www.pharmacompass.com/image/flap/abbvie-corp-adgif-27965.gif)
![AbbVie](https://www.pharmacompass.com/image/flap/abbvie-corp-ad-w33-mob-headergif-39012.gif)
20
Jilin Shulan Synthetic Pharmaceutical Co. Ltd. Shulan City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Theophylline-ethylenediamine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2004-140 - Rev 00
This Chemical Type CEP, issued on September 19, 2011, remains in force until February 27, 2014, ensuring its reliability within the pharmaceutical industry.
Substance Number 300 associated with this CEP further emphasizes